Famvir Approved in the UK for Suppression Of Recurrent Genital Herpes
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Famvir Approved in the UK for Suppression Of Recurrent Genital Herpes

LONDON, May 16, 1997 -- SmithKline Beecham’s antiviral drug Famvir(famciclovir) has been approved for use in the suppression of recurrent genital herpes (herpes simplex) in the United Kingdom. This is the first market to launch Famvir for this condition anywhere in the world.

Famvir was previously approved in the UK for the treatment of shingles (herpes zoster) and genital herpes. In the United States Famvir is indicated for the treatment of recurrent genital herpes and shingles in immunocompetent individuals. It is under review in the U.S. for suppression of recurrent genital herpes.

SmithKline Beecham discovers, develops, manufactures and markets pharmaceuticals, vaccines, over-the-counter medicines and health-related consumer products and provides healthcare services including clinical laboratory testing, disease management and pharmaceutical benefit management.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities